PublizoomAward notice Services
Speed up the development of and access to innovative medical countermeasures - Point of care metagenomic sequencing for universal pathogen detection.
- Public buyer
- Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
Brussels - Place of performance
- 1210 Brussels
not published: buyer's address - Estimated value
- €24,000,000 excl. VAT
- Amount awarded
- €23,993,818 excl. VAT
- Planned end of contract
- 19 December 2028
likely re-tender around June 2028 - Bids received
- 6
- Procedure
- Competitive negotiated procedure
You first submit an application; shortlisted candidates bid, then negotiate with the buyer. - Publication
- 13 January 2025
- Notice language
- English
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
This procedure supports the development of a metagenomic next-generation sequencing (mNGS)-based test that can detect any respiratory/airborne viral pathogen, including novel and emerging, from any human respiratory sample type.
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
73000000 73300000
Winning prices for comparable contracts
- A quarter below
- €361,602
- Median
- €984,500
- A quarter above
- €3,554,250
Amounts awarded (excl. VAT) over the last 3 years for 127 contracts in the same CPV group (7300…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 20159-2025.